Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of CLR2.0 Hemofiltration Treatment (C2Rx) in Severe or Critically Ill Adults With COVID-19 Infection

NCT04537975 is registered in ClinicalTrials.gov with SeaStar Medical as lead sponsor.

NCT NCT04537975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of CLR2.0 Hemofiltration Treatment (C2Rx) in Severe or Critically Ill Adults With COVID-19 Infection
Lead sponsor
SeaStar Medical
Phase
Not applicable
Overall status
Withdrawn
Start date
September 15, 2020
Completion date
January 15, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

continuous renal replacement therapy, covid-19, pulmonary edema